Scope and Editorial Policy The mission of the Journal, WomensHealthSection.com is to publish and disseminate scientifically rigorous public health information, with special focus on women’s health, of national and international significance that enables health care providers, policy-makers, and researchers to be more effective. It aims to improve health, particularly among disadvantaged populations in both developed and developing countries. Women’s Health and Education Center (WHEC) welcomes unsolicited manuscripts, which are initially screened in-house for originality and relevance. Manuscripts passing the initial screening are sent blindly for peer review. After the reviews have been received, the editorial advisers decide on the manuscript’s acceptability for publication in WomensHealthSection.com. Accepted papers are subject to editorial revision, including shortening of the text and omission of tables and figures if appropriate. The word limits shown below do not include the abstract (where applicable), tables, figures and references. The principal types of manuscripts are outlined below. I. Unsolicited Manuscripts 1.1 Letters. Useful contributions referring to something published recently in the WomensHealthSection.com or WHEC Update; 400-850 words, maximum 3 references. Letters are also edited and may be shortened. 1.2 Policy & Practice. Reviews, debates or hypothesis-generating papers; not more than 3,000 words, with a non-structured abstract (see below 3.5) and not more than 25 references; peer reviewed. 1.3 Research. Methodologically sound primary research of relevance to women’s health and health development. Formal scientific presentations of not more than 3,000 words, with a structured abstract (see below) and not more than 25 references; peer reviewed. 1.4 Systematic reviews in women’s health. Exhaustive, critical assessments of published and unpublished studies (grey literature) on research questions of relevance to women’s health and practice are welcome. Reviews should be prepared in strict compliance with MOOSE or QUOROM (PRISMA) guidelines or with Cochrane’s complementary guidelines for systematic reviews of health promotion and public health interventions. Not more than 3,000 words and 25 references, plus a 250-word structured abstract (see below 3.5). All studies included and excluded in the review should be shown in a flow diagram that will not count towards the word limit if published as an appendix only in the electronic version of the journal or on the author’s URL. Peer reviewed. 1.5 Perspectives. Views, hypotheses or discussions (with clear message) of an issue of women’s health interest; up to 1,500 words, no more than 6 references. 1.6 Lessons from the field. Papers that capture experiences and practice gained in solving specific women’s health problems in both developed and developing countries, with a structured abstract (see below); not more than 1,500 words and not more than 10 references, with no more than one table and one figure. II. Commissioned manuscripts The categories of articles shown below are normally commissioned by the editors. Authors wishing to submit and unsolicited manuscript to be considered for one of these categories should first contact editorial office. 2.1 Editorials. Authoritative reviews, analyses or views of an important topic related to the various themes in women’s health or an important health development subject; not more than 800 words, maximum 6 references. 2.2 Round tables. Consist of a base paper on a controversial subject of current women’s health issue of national and international importance (not more than 2,000 words and an abstract) and a debate on it by several discussants, who are invited to contribute not more than 500 words each. 2.3 Books & electronic media. Reviews of a book, web-site, CD-ROM, etc. of women’s health interest; 400-800 words, no references. 2.4 Current commentaries. Explanatory or critical analysis of an individual article; not more than 800 words, maximum 6 references. 2.5 Public health classics. A landmark public health paper which focuses on women’s health and achieving universal access to reproductive health or publication is reproduced, accompanied by a commentary of up to 1,500 words. III. Preparation and Submission of Manuscripts Manuscripts should be prepared in accordance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals established by the Vancouver Group (International Committee of Medical Journal Editors, ICMJE). The complete document, updated October 2007, is available at: http://www.icmje.org 3.1 Languages. Manuscripts should be submitted in English. Authors who have difficulty in preparing their manuscript in English should contact the editorial office for advice. 3.2 Authorship. Authors should give their full names and the name and address of their institutions. If possible, only one institution per author should be given. In accordance with the “Uniform requirements” (see above), each author should have participated sufficiently in the work being reported to take public responsibility for the content; each author should provide a description of his or her contribution to the work being reported. The full postal and e-mail address of the corresponding author will be published unless otherwise requested. The WomensHealthSection.com encourages submissions from authors in developing countries, and in line with this policy at least one author should be a national of the country where the study was carried out and have an affiliation there. 3.3 Automatic links: All links inserted by the automatic reference and footnote facilities of word-processing software must be removed before the manuscript is submitted. Footnotes are not permitted and such material should be inserted into the main text. 3.4 Tables and figures: Tables and figures should be used only if they enhance understanding of the text. In the text, tables and figures should be numbered consecutively (e.g. Table 1, Fig. 1). They should be presented with clear, concise titles at the end of the text and not incorporated or embedded into it. Abbreviations or acronyms should be avoided but if used must be explained. Graphs or figures, which should be presented in two-dimensional and not pseudo three-dimensional “perspective” format, should be clearly drawn and all the data identified. 3.5 Abstracts. Abstracts, which should be clearly written to highlight the text’s most significant points, should be provided for the following types of papers: Research, Systematic reviews, Policy & practice, base papers for Round tables and Lessons from the field. The abstract, which should not exceed 250 words, appears in WomensHealthSection.com and WHEC Update. 3.6 Competing interest. A competing interest arises when a professional judgment concerning a primary interest (such as patient’s welfare or the validity of research) may be influenced by a secondary interest (such as financial gain or personal rivalry). We ask all authors to disclose at the time of submission any competing interests that may have. Examples of types of competing interests may be found at: http://www.icmje.org. 3.7 Funding. Authors should declare sources of funding for the work undertaken; affirm that they have not entered into an agreement with the funding organization that may have limited their ability to complete the research as planned, and that they have had full control of all primary data. 3.8 Ethical issues. The Women’s Health and Education Center (WHEC) publishes the results of research involving human subjects only if it has been conducted in full accordance with ethical principles, including the provisions of the World Medical Association Declaration of Helsinki (as amended by the 59th General Assembly, October 2008; available at: http://www.wma.net/ ) and the additional requirements, if any, of the country in which the research was carried out. Any manuscript describing the results of such research that is submitted for publication must contain a clear statement to this effect, specifying that the free and informed consent of the subjects or their legal guardians was obtained and that the relevant institutional or national ethical review board approved the investigation. 3.9 Maps. Use of maps should be avoided, but should their use be necessary authors are requested to use the relevant UN-approved maps, which can be downloaded from: http://www.un.org/Depts/Cartographic/english/htmain.htm 3.10 Bibliographic references. Authors are responsible for the accuracy of all references, which should be verified at: http://www.ncbi.nlm.nih.gov : these are not checked by editors. References should be numbered consecutively as they occur in the text (in superscript roman type, preferably at the end of a sentence) and listed in numerical order at the end of the text. WomensHealthSection.com adheres closely to the Vancouver style of references (see http://www.icmje.org updated October 2007). The first three authors of a work should be named, followed by “et al”. If there are more than three.Read More

9 November 2004 Dear Dr Luthra, I acknowledge with thanks your letter of 20 October 2004, introducing your Organization. We have taken due note of your initiative. Please be advised, however, that as UNESCO is mainly devoted to the promotion of intellectual cooperation in education, science, culture and communication, it would seem more appropriate for you to contact the World Health Organization, WHO, which should be able to help you in connection with your request which focuses on health related issues. Thanking you for your interest in UNESCO and wishing you every success in your activities, I remain, Yours sincerely, Massoud Abtahi Chief Section of International Non-Governmental Organizations and FoundationsRead More

Director, Division of Female Pelvic Medicine and Reconstructive Surgery, Maimonides Medical Center Assistant Professor, New York Medical School Brooklyn, USA glevy@maimonidesmed.org [در.] [لفي] يميّز زعيمة في المجال من [أوروجنكلوج] و [ركنستروكتيف] جراحة حوضيّة ، يختصّ في المعالجة من هبوط حوضيّة ، [إينكنتيننس] بوليّة ، ويتقدّم جراحة حوضيّة. هو قد ألّف مواد علميّة ، بحث ملخصات وأعراض سريريّة. يقود [در.] [لفي] أيضا [ر&د] مشاريع يطوّر أجهزة إبداعيّة جراحيّة وهو قد ألّف يتعدّد ينشر براءة اختراع عالميّا. هو كان سابقا المديرة من [أوروجنكلوج] برنامج في جبل سيناء [مديكل سنتر] في منهاتن. هو حاليّا مديرة من الطبّ أنثويّة حوضيّة و [ركنستروكتيف] جراحة حوضيّة في [ستتن يسلند] جامعة مستشفى و [ميمونيدس] [مديكل سنتر] بروكلين [ني]. استلم [در.] [لفي] درجته طبيّة في 1987 من [سكلر] كلية الالطبّ ، [تل فيف] جامعة ، إسرائيل. بعد يتمّ عمله أكاديميّة ، دكتورة دخل ضريبة ال [أب/جن] مقر برنامج في [لونغ يسلند] كلية مستشفى ، يتخرّج مع فائدة خاصّة في جراحة حوضيّة. هو بعد ذلك بدأ تدريبه [بوستغردوت] في [أوروجنكلوج] و [ركنستروكتيف] جراحة حوضيّة في جبل سيناء [مديكل سنتر] ، [ني]. بعد يتمّ تدريبه ، دعات هو كان أن يبقى في القسم من علم قبالة و [جنكلوج] ك [أسّيستنت بروفسّور] ومديرة من [أوروجنكلوج] برنامج حيث هو أسّس مقاربة متعدّد مناهج إلى اختلال وظيفيّ أنثويّة حوضيّة مع تورط من اختصاصيّ البول ، جراحات [كلو-ركتل] واختصاصيّ الشّيخوخة. في يوليو-تمّوز 2000 أصبح هو المديرة من الطبّ أنثويّة حوضيّة و [ركنستروكتيف] جراحة في ال [ستتن يسلند] جامعة مستشفى وفي يونيو – حزيران 2002 هو قبل إضافيّة تقسيم [ديركتورشيب] في [ميمونيدس] [مديكل سنتر]. يؤسّس [در.] [لفي] حاليّا المعهد لأنثويّة حوضيّة أرضية اختلال وظيفيّ – برنامج متعدّد مناهج مع [دينوستيك فسليتي] أحدث بما في ذلك [أنو/ركتل] علم وظائف الأعضاء مختبرة ، ويتعدّد معالجة شكليات لحوضيّة جهاز هبوط وبوليّة/[إينكنتيننس] برازيّة. [در.] [لفي] يتضمّن فوائد حاليّة [مينيملّي] جراحة جائحة حوضيّة و [أدفنسد تشنولوج] للمعالجة من هبوط ، إصابات مهبليّة [أنتوميكل] و [إينكنتيننس]. يتضمّن تقنياته إبداعيّة جراحيّة [مينيملّي] أجهزة جائحة جراحيّة ، [ريسك فكتور] قباليّة لحوضيّة أرضية اختلال وظيفيّ ، وقباليّة ناسور إصلاحات. يبدأ [در.] [لفي] برنامج لمعالجة من نواسير قباليّة في نيامي ، نيجر مع المساندة من التنظيم دوليّة لنساء وتطوير. هو المديرة طبيّة من هذا برنامج ويقود مهام [بي-مونثلي] جراحيّة إلى الأمة [أفريكن] نيجر ، حيث هو ينجز جراحات إصلاحيّة في المستشفى وطنيّة نيامي. هو حاليّا [بوأرد ممبر] [رتل] طبيّة ؛ محققة رئيسيّة ل ال [ستتن يسلند] [أورولوج] [رسرش غرووب] ومستشارة علميّة من عدّة ذو رأسمال مجازفة طبيّة تكنولوجيا شركات.Read More

Chairman, Department of Obstetrics and Gynecology St. Elizabeth’s Medical Center Boston, MA (USA) Education: Graduated from Harvard College, 1952-56 Served in United States Navy (Ensign-Lt jg), 1956-58 Boston University School of Medicine, 1958-62 Internship/residency surgery St. Vincent’s Hospital NY, NY, 1962-64 Ob/Gyn residency St. Vincent’s Hospital NY, NY, 1964-68 Experience: Clinical Professor of Ob/Gyn, Tufts University School of Medicine President, Obstetrical Society of Boston, 1999-2000 Chairman, Massachusetts Section ACOG, 1998-2002 Chairman, Department of Ob/Gyn, St. Elizabeth’s Medical Center, Boston MA St. Elizabeth’s Medical Center is devoted to women’s health care issues and welcomes projects related to safe motherhood from all over the world. Our residency program has residents from various countries and ethnic backgrounds. Our diversity is our strength.Read More

New York Main Representative at UN for NGO Women’s Health and Education Center (WHEC) 300 Stafford Street; Suite 265 Springfield, MA 01104 USA Telephone: 413-733-1177 Fax: 413-733-0425 e-mail:jriverawhec@gmail.com Born in Puerto Rico in 1971, Joanne Rivera has resided in New York City since 1990. Mother of 3 children, one boy and two girls, she has dedicated her work to improve maternal and child health. All throughout school and college education at Greenfield Community college and Bay State Mini Medical School in Massachusetts, the emphasis was on: make all efforts to understand different customs and learn to respect the differences. She is bilingual (English and Spanish) and welcomes challenges to resolve conflicts. Her extensive training includes: management, scheduling, money-management, organize and supervise care for the disabled. She has provided care for consumers with severe medical disabilities, hip and knee joint replacements, seizures, cerebral palsy, and incontinence. Her expertise also includes accurate records of medication, progress notes, safety plan and wound care. She has worked for 4 years with Behavioral Health Network and Western Massachusetts Elder Care, Inc. before joining Women’s Health and Education Center (WHEC). Joined in 2007 as Office Manager of Women’s Health and Education Center (WHEC) she has worked tirelessly to get various projects and programs of WHEC, in maternal and child health, off the ground. That is how the interest in international project and program development started. As we begin our next chapter of the development of this Global Initiative, we all welcome her in the challenging role of Main NGO Representative of WHEC at the United Nations. Working at WHEC her duties include: coordinating collaboration with a diverse group of professionals from United Nations, intra-country, national, regional and local agencies, universities, schools of public health, community organizations and professional societies. We hope our efforts are helpful in implementing improved and informed care. We hope that our initiatives will provide a useful factual basis for action, for all those working for Safe Motherhood.Read More

Professor of Obstetrics and Gynecology Chief, Division of Maternal-Fetal Medicine University of Utah Health Sciences Center (UUHSC) 30 North 1900 East SOM 2B200 Salt Lake City, UT 84132 (USA) Tel: 801-585-5156 Fax: 801-585-2594 E-mail: robert.silver@hsc.utah.edu Education and Training: INSTITUTION AND LOCATION DEGREE YEAR (s) FIELD OF STUDY University of Pennsylvania, Philadelphia, PA BA 1982 Microbiology Medical College of Pennsylvania, Philadelphia, PA MD 1986 Medicine University of Colorado Health Sciences Center, Denver, CO Residency 1986-1990 Obstetrics and Gynecology University of Utah Health Sciences Center (UUHSC), Salt Lake City, UT Fellowship 1990-1994 Maternal-Fetal Medicine A. Positions and Honors Positions 1990-1991 Clinical Instructor, Department of Ob/Gyn, UUHSC, SLC, UT 1992-1994 Instructor, Department of Ob/Gyn, UUHSC, SLC, UT 1994-1998 Assistant Professor, Department of Ob/Gyn, UUHSC, SLC, UT 1998-2006 Associate Professor with tenure, Department of Ob/Gyn, UUHSC, SLC, UT 2006-present Professor with tenure, Department of Ob/Gyn, UUHSC, SLC , UT 1995-2003 Residency Director, Department of Ob/Gyn, UUHSC, SLC, UT 2001-present Medical Director of Labor and Delivery, UUHSC, SLC, UT 2000-present Division Chief, Maternal Fetal Medicine, Department of Ob/Gyn, UUHSC, SLC, UT Honors 1985 Kurt Pauker Achievement Award for Excellence in Microbiology 1986 Alpha Omega Alpha 1993-1998 Research Scientist Development Program, National Institutes of Health 2000 Poster Award (best of session): IgA beta-2-glycoprotein-I Antibodies are Elevated in Women with Unexplained Recurrent Spontaneous Abortion and Unexplained Fetal Death, Society for Gynecologic Investigation 2001 Poster Award (best of session): Heparin-induced Thrombocytopenia is Rare in Pregnancy, Society of Perinatal Obstetricians 18th Annual Meeting 2003 Poster Award (best of meeting): Stillbirth in Utah from 1995-2001 B. Peer-Reviewed Publications Select peer-reviewed publications (in chronological order) Mitchell MD, Edwin SS, Lundin-Schiller S, Silver RM, Smotkin D, Trautman MS. (1993). Mechanism of interleukin-1 beta stimulation of human amnion prostaglandin biosynthesis: mediation via a novel inducible cyclooxygenase. Placenta 1993; 14:615-25. Edwin SS, Branch DW, Scott JR, Silver RM, Mitchell MD. Cyclosporin A attenuates increased prostaglandin and thromboxane production in response to various stimuli in human decidua. Am J Reprod Immunol 1993;30: 154-9. Silver RM, Draper ML, Scott JR, Lyon JL, Byrne SL, Ashwood EA, Branch DW. Unexplained elevations of maternal serum alpha-fetoprotein in women with antiphospholipid antibodies: A harbinger of fetal death. Obstet Gynecol 1993; 83:150-5. Silver RM, Draper ML, Scott JR, Lyon JL, Reading J, Branch DW. Clinical consequences of antiphospholipid antibodies: An historical cohort study. Obstet Gynecol, 1994;83:372-7. Mitchell MD, LaMarche S, Adamson S, Coulam C, Silver RM, Edwin SS. Regulation of intrauterine prostaglandin biosynthesis interactions between protein kinase C and interleukin 1Β. Prost Leuk EFA 1994;50:137-40. Silver RM, Edwin SS, Trautmna MS, Simmons DL, Branch DW, Dudley DJ, Mitchell MD. Bacterial lipopolysaccharide mediated fetal death: Production of a newly-recognized form of inducible cyclooxygenase (COX-2) in murine deciduas in response to lipopolysaccharide. J Clin Invest 1995;93:725-31. Silver RM, Pierangelli SS, Gharavai AE, Harris EN, Edwin SS, Salafia CM, Branch DW. Induction of high levels of anticardiolipin antibodies in mice by immunization with Β2-glycoprotein 1 does not cause fetal death. Am J Obstet Gynecol 1995;173L1410-5. Silver RM, Porter TF, van Leeuwen I, Coulam C, Jeng G, Scott JR, Branch DW. Anticardiolipin antibodies: Clinical consequences of low titers. Obstet Gynecol 1996;87:494-500. Oshiro BT, Silver RM, Scott JR, Yu H, Branch DW. Antiphospholipid antibodies and fetal death. Obstet Gynecol 1996;87:489-93. Edwin SS, Branch DW, Scott JR, Silver RM, Dudley DJ, Mitchell MD. Cyclosporin A inhibits prostaglandin E2 production by fetal amnion cells in response to various stimuli. Prostaglandins 1996;52:51-61. Branch DW, Silver RM. Criteria for antiphospholipid syndrome: early pregnancy loss, fetal loss, or recurrent pregnancy loss? Lupus 1996;5:409-13. Branch DW, Silver RM, Pierangeli SS, van Leeuwen I, Harris EN. Antiphospholipid antibodies other than lupus anticoagulant are not associated with recurrent pregnancy loss. Obstet Gyencol 1997;89:549-55. Silver RM, Edwin SS, Umar F, Dudley DJ, Branch DW, Mitchell MD. Bacterial lipopolysaccharide-mediate fetal death: The role of interleukin-1. Am J Obstet Gynecol 1997;176:544-9. Silver RM, Pierangeli SS, Edwin SS, Umar F, Harris EN, Scott JR, Branch DW. Pathogenic antibodies in women with obstetric features of antiphospholipid syndrome who test negative for lupus anticoagulant and anticardiolipin antibodies. Am J Obstet Gynecol 1997;176:628-33. Silver RM, Smith LA, Edwin SS, Oshiro BT, Scott JR, Branch DW. Variable effects of immunoglobulin G fractions from women with antiphospholipid antibodies on murine pregnancy. Am J Obstet Gynecol 1997;177:229-33. Coulam CB, Clark DA, Beer AE, Kutteh WH, Silver RM, Kwad J, Stephenson M. Current clinical options for diagnosis and treatment of recurrent spontaneous abortion. Am J Reprod Immunol 1997;38:57-74. Edwin SS, Mitchell MD, Silver RM, Branch DW, Dudley DJ. Ceramide stimulates prostaglandin production by human amnion and decidual cells J Soc Gynecol Invst 1997;4:274-8. Gharavi AE, Cucurull E, Tang H, Silver RM, Branch DW. Effect of antiphospholipid antibodies on beta-2-glycoprotein I-phospholipid interaction. Am J Reprod Immunol 1998;39:310-5. Kutteh WH, Rote NS, Silver RM. Antiphospholipid antibodies and reproduction. Am J Reprod Immunol 1999;41:133-154. Pregnancy loss study group (Branch DW, Druzin M, El-Sayed Y, Esplin MS, Hrager J, Peaceman AM, Silver RK, Silver RM, Spinnato J). A multicenter, controlled, pilot study of intravenous immune globulin treatment antiphospholipid syndrome in pregnancy. Am J Obstet Gynecol 2000;182:122-7. Van-Horn JT, Craven C, Ward K, Branch DW, Silver RM. Histologic features of gestational tissues from women with antiphospholipid and antiphospholipid-like syndromes. Placenta 2004;25:642-8. Ornoy A, Chen L, Silver RM, Mosmann TR, Miller RK. Maternal autoimmune diseases and immunologically-induced embryonic and feto-placental damage. Birth Defects Res Part A Clin Mol Teratol 2004;70:71-81. Frias AE, Luikenaar RA, Sullivan AE, Porter TF, Branch DW, Silver RM. Poor obstetric outcome in subsequent pregnancies in women with prior fetal death. Obstet Gynecol 2004;104:521-6. Sullivan AE, Silver RM, LaCoursiere DY, Porter TF, Branch DW. Does recurrent aneuploidy contribute to recurrent miscarriage? Obstet Gynecol 2004;10:784-8. Sullivan AE, Nelson L, Rice JA, Porter TF, Branch DW, Silver RM. The factor V Leiden and the G20210A prothrombin gene mutations are rare in women with fetal death. Am J Reprod Immunol 2005;54;1-4. Sullivan AE, Nelson L, Silver RM, Frias AE, Porter TF, Branch DW. The aryl hydrocarbon receptor nuclear tranlsocator gene polymorphism in patients with recurrent miscarriage. Am J Reprod Immunol 2006;55(1): 51-3 Silver RM, Landon MB, Rouse DC, Leveno JK, Spong CY, Thom EA, et al. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol 2006;107(6): 1226-32. Silver RM. Fetal Death. Obstet Gynecol 2007;109(1):153-67. Silver RM, Varner MW, Reddy U, Goldenberg R, Pinar H, Conway D, Bukowski R, Carpenter M, Hogue C, Willinger M, Dudley D, Saade G, Stoll B. Work-up of stillbirth: a review of the evidence. Am J Obstet Gynecol 2007;196:433-44. Warren JE, Silver RM, Nelson L, Dalton J, Porter TF, Branch DW. Cervical insufficiency: a genetic condition? Collagen 1?1 intron SP1 and transforming growth factor-? ARG-25-PRO polymorphisms in women with cervical insufficiency. Obstet Gynecol 2007;110:619-24. Raju TN, Nelson KB, Ferriero D, Lynch JK; NICHD-NINDS Perinatal Stroke Workshop Participants. Pediatrics 2007;120:609-16. Holmgren C, Esplin MS, Hamblin S, Esplin MS, Molenda M, Silver RM. Evaluation of the use of anti-TNF-alpha in an LPS-induced murine model. J Reprod Immunol 2008; Epub, April 21. Silver RM. New anticoagulants and pregnancy. Obstet Gynecol 2008;112:419-20. Silver RM. Immune activation early in pregnancy: trouble down the road. Am J Obstet Gynecol 2008, 199;327-8. Holmgren C, Porter TF, Varner MW, Aagard K, Silver RM. Hyperemesis in pregnancy: A comparison of treatment strategies. Am J Obstet Gynecol, 2008;198:56e1-4. Turok DK, Gurtcheff S, Esplin MS, Shah M, Simonsen SE, Shah M, Trauscht-Van Horn J, Silver RM. Second trimester termination of pregnancy: A review by site and procedure type. Contraception 2008;77:155-61 Peltier MR, Faux DS, Hamblin SD, Cooper C, Silver RM, Esplin MS. Effect of aspirin treatment on TNF-? Production by women with a history of preterm birth. J Reprod Immunol 2009;80:109-14. Warren JE, Silver RM, Branch DW, Porter TF. Thromboprophylaxis and pregnancy outcomes in asymptomatic women with thrombophilias. Am J Obstet Gynecol 2009;200:281.e1-5. Warren JE, Nelson L, Esplin MS, Silver RM. Interleukin-10 polymorphisms and cervical insufficiency. Am J Obstet Gynecol 2009;201:372-4. Manuck TA, Eller AG, Esplin MS, Stoddard G, Varner MW, Silver RM. Outcomes of expectantly managed preterm premature rupture of membranes occurring ? 24 weeks gestation. Obstet Gynecol 2009;114:29-37. Reddy UM, Goldenberg R, Silver R, Smith GCS, Pauli RM, Wapner RJ, et al. Stillbirth classification: developing an international consensus for research: Executive summary of NICHD workshop. Obstet Gynecol 2009;114:901-14. Manuck TA, McLean, Varner MW, Silver RM. Preterm premature rupture of membranes: does the duration of latency influence neonatal outcome? Am J Obstet Gynecol 2009;201:414-6. Warren JE, Turok DK, Maxwell TM, Brothman AR, Silver RM. Array comparative genomic hybridization (aCGH) for genetic evaluation of fetal loss between 10 and 20 weeks gestation. Obstet Gynecol 2009;114:1093-1102. Clark EAS, Lacoursiere DY, Byrne JLB, Ponder R, Silver RM, Esplin MS. Reliability of fetal MCA velocity: a randomized controlled trial of sonographer training. J Ultrasound Med 2009;28:19-25. Grosvenor Eller A, Silver RM, Zempolich K, Soisson P, Simonson SE. Optimal management of placenta accreta. Br J Obstet Gynecol 2009;116:648-54. Peltier MR, Faux DS, Hamblin SD, Silver RM, Esplin MS. Cytokine production by peripheral blood mononuclear cells of women with a history of preterm birth. In press, J Reprod Immunol. Silver RM, Zhao Y, Spong C, Caritis SN, Sibai B, Wendel G Jr., et al. Prothrombin gene G20210A mutation and obstetric complications: a prospective cohort. In press, Obstet Gynecol. C. Research Support Ongoing Support NIH/NICHD 1U10HD063053-01 Preterm Birth in Nulliparous Women: An Understudied Population (Silver)12/01/2009-11/30/2014 This Network will design and execute a prospective, longitudinal cohort study of 10,000 nulliparous women. The research protocols developed will determine characteristics that influence and/or predict adverse pregnancy outcomes in nulliparous women including genetics, epigenetics, physiological response to pregnancy, interaction with environmental exposures, fetal growth and development, and placental development and function. Role: PI NIH/NICHD 3U10HD045944-05S2 Research on the Scope and Causes of Stillbirth in the United States (Silver)09/26/2003–07/31/2009NCX The major goals of this project are to develop a network of collaborating academic centers to study the extent and causes of stillbirth and to develop methods for stillbirth prevention. Role: PI NIH/NICHD HHSN267200603423C / N01DK63423 (Silver)09/30/2006-09/29/2011 The Effects of Aspirin in Gestation and Reproduction The purpose of this contract is to evaluate the effect of daily low-dose aspirin on all phases of reproduction beginning at preconception and continuing throughout pregnancy, including implantation and live births. Role: PIRead More

Address Telephone Number UMA 4581 402-559-4212 – office 983255 Nebraska Medical Center 402-559-5015 – office fax Omaha, NE 68198-3255 Email: nagarwala@unmc.edu USA Objective Providing comprehensive gynecological and urogynecological care, and participating in student, resident teaching along with research and surgical activities. Special Interests Laparoscopic Hysterectomy and Myomectomy. Laparoscopic Management of Pelvic Pain and Endometriosis. Laparoscopic and vaginal Urinary Incontinence Procedures. Laparoscopic and vaginal Pelvic Prolapse Procedures. Laparoscopic Infertility Surgery. Laparoscopic Lysis of Adhesions. Interstim placement for Intractable urgency, frequency. Education and Training Fellowship in Advanced Laparoscopic and Urogynecological Surgery, sponsored by American Association of Gynecological Laparoscopists (AAGL) and Society of Reproductive Medicine (SRM), Preceptor : Dr. C.Y. Liu, M.D., Director, Chattanooga Women’s Laser Center. 7/2001-7/2002. PGY 4, Chief Resident, OB/GYN, Penn State Geisinger Health System, Danville. 7/99 -6/2000 PGY 2-3, Obstetrics & Gynecology, Penn State Geisinger Health System, Danville. 6/97 -6/99. PGY-2, Obstetrics and Gynecology, University of California at Los Angeles. Aug 96 – Nov 96. PGY-1, Obstetrics and Gynecology, University of California at San Francisco. June 95- July 96. M.D., Milton S. Hershey Medical Center, The Pennsylvania State University, May 1995. M.S., Molecular and Cell Biology, The Pennsylvania State University, 1990, G.P.A. – 4.0 / 4.0. B.Pharm., Pharmaceutical Sciences, Birla Institute of Technology, India.1986, G.P.A.- 3.94/4.0. Fellowship Training Extensive training in complex laparoscopic procedures with special emphasis on Endometriosis, Pelvic Floor Reconstruction, Urogynecologic and Reproductive Surgery procedures. Residency Training Excellent evaluations throughout the residency training. Developed strong interest in providing most compassionate and humane care to a multicultural and diverse population. Actively involved in resident and medical student teaching. Worked on clinical research topics such as evaluating the largest vertical pocket of amniotic fluid as an indicator of Amniotic Fluid Index. Observational training in advanced endoscopic surgery for one month with Drs. C.Y.Liu and C. Koh. Clinical Work Experience Assistant Professor, Dept of Obstetrics and Gynecology, Urogynecology and Advanced Laparoscopic Surgery, University of Nebraska Medical Center, Omaha, NE, Oct 2002 – current. Consultant for Labor and Delivery at Eastridge Hospital, Chattanooga, TN, Aug 2001-June 2002. Staff Physician at Nason Hospital, Roaring Springs, PA, July 2000-June 2001. Currrent Research Activities An Open-Label Study of the Efficacy and Safety of 5 and 10 mg Vesicare ( Solifenacin Succinate) in patients with Overactive Bladder Symptoms. VOLT Vesicare Open-Label Trial Principal Investigator for UNMC site. IRB approval # 290-04 FB. Comparison of Efficacy, Cost-Effectiveness, and Patient Satisfaction of Ondansetron or Granisetron plus Dexamethasone or Dexamethasone alone in Preventing Post-Operative Nausea and Vomiting. PONV Study Secondary Investigator and Primary surgeon. IRB approval # 156-03 FB Urethral Retro-Resistance Pressure correlation with Urodynamic Measurements in normal Females using Gynecare Monitorr Device – Residency Program Education. Laparoscopic Surgical and Urogynecological minimally invasive surgery evaluations. Clinical Advancement Activities Laparoscopic Task Force, Gynecology Representative at The Nebraska Medical Center Educational Speaker for Pfizer, Watson, Wyeth, Odyssey and Yamanouchi. Storz Hysteroscopic Advances, Boston, March 2005. SIS Summit – Multidisciplinary conference for biomaterials, Cook Biotech., Santa Fe, March 2005. Speaker’s Bureau program for Odyssey, February 2005. Gynecare TVT-O Training Program, January 2004. Boston Scientific Innovations in Pelvic Floor Reconstruction and Stress Urinary Incontinence Program, September 2004. Interstim Therapy Training Program, August 2003. Cook Stratasis Mentor Program, June 2003. Research Work Experience Research Scientist, October 1986-August 1991, Zetachron, Inc., State College, Pennsylvania. Co-Inventor on two U.S. patents for sustained release super cooling drug formulations and enteric acting dosage forms. Designed and developed dosage forms for controlled-release oral and buccal delivery systems for drugs under these categories: analgesics, antihypertensives, CNS stimulants, bronchodilators, antiemetics, antihistamines, antibiotics, hormones, and vitamins.Worked on stability and kinetics of new dosage forms using dissolution apparatus, spectrometry, chromatography, and pH meters. M.S. Thesis on Parathyroid Hormone receptors on osteoclasts, June 1989 – December 1990. Used gel chromatography, iso-electric focusing, advanced light and fluorescence microscopy. Presented a poster and a seminar on this research work at a graduate research exhibition and at the American Society for Cell Biology meeting. Graduate coursework: Neurophysiology, Evaluation of Cell Functions, Molecular Biology and Cell Regulation, Tumor Virology and Oncology, Carbohydrates, and Mathematical Methods. Academic Honors and Awards Earned academic grade of honors and excellent evaluations in all clerkships during the third and forth year of medical school. High scores on all. National Board Subject Examinations for clerkships (93rd-100th percentile). Consistently achieved honors grade and top rank in almost all courses, both basic science and clinical, during the first two years of medical school. AWARDS Jerome J Hoffman Postgraduate Prize at the AAGL 33rd Annual Meeting, San Francisco, November 2004. Best Fellow Award -2002 at The Chattanooga Women’s Laser Center by Hospital and OR Staff. Best Resident Teaching Award for 1999-00 at PSGHS by Thomas Jefferson Medical Student Committee Selected for the 1999 ACOG Wyeth-Ayerst Resident Reporter Program for ACOG Berlex Laboratories PGY-2 Best Teaching Resident Award for 1997-98 at PSGHS Selected for the 1998 CREOG/Wyeth-Ayerst Educational Resident Reporter Program. Alpha Omega Alpha Medical Honor Society, elected during the junior year of medical school Hammond Award for outstanding academic performance in the first, second, and third year of medical school. Only student in medical school class to win the award for three consecutive years Virchow Prize for excellence in Pathology from the Department of Pathology in 1993 First Rank holder in thel 986 batch of B.Pharm students and University-wide gold medalist G.P. Nair Award from the Indian Drug Manufacturers Association in 1986. Publications Agarwala, N. Laparoscopic hysterectomy for morbidly obese patients, Submitted for presentation at the AAGL 34th Annual Meeting Agarwala, N., Cohen, A. Experience with Laparoscopic Hysterectomy in a teaching University Hospital. Submitted for presentation at the AAGL 34th Annual Meeting Agarwala, N. Laparoscopic bilateral uterosacral ligament suspension for vaginal prolapse. Submitted for presentation at the AAGL 34th Annual Meeting Agarwala, N, Briggs, A,. Laparoscopic Sacral Colpopexy for recurrent vault prolapse, Video presentation for the AAGL 34th Annual Meeting Agarwala, N. To compare synthetic and biologic materials for tension free sling in women with stress incontinence. Presented at American College of Obstetricians and Gynecologists’ 53rd Annual Clinical Meeting, May 2005. Agarwala, N. Ortiz, A., Colpocleisis and tension-free vaginal sling for pelvic prolapse and stress urinary incontinence. Presented at American College of Obstetricians and Gynecologists’ 53rd Annual Clinical Meeting, May 2005. Agarwala, N. To identify urodynamic characteristics of long term Burch colposuspension failures. Presented at American College of Obstetricians and Gynecologists’ 53rd Annual Clinical Meeting, May 2005. Agarwala, N., Liu, C.Y. Safe entry Techniques During Laparoscopy: Left Upper quadrant Entry Technique Using the Ninth Intercostal Space – A Review of 918 Cases. The Journal of Minimally Invasive Surgery, Vol 12, No 1, 55-61. Agarwala, N., Liu, C.Y. To evaluate biomaterials for mid-urethral sling procedures. American College of Obstetricians and Gynecologists’ 52nd Annual Clinical Meeting, May 2004. Agarwala, N. Simple technique for reduction of post-operative gas pain after Laparoscopy. American College of Obstetricians and Gynecologists’ 52nd Annual Clinical Meeting, May 2004. Agarwala, N., Liu, C.Y. Laparoscopic Uterosacral Vault or Uterine suspension: Our experience. The Journal of the American Association of Gynecologic Laparoscopists, Vol. 10, No. 3 Supplement, Aug 2003. Agarwala, N., Liu, C.Y. Minimally Invasive Management of Stress Urinary Incontinence. Current Opinions in Obstetrics and Gynecology. October 2002. Agarwala, N., Liu, C.Y. Laparoscopic Appendectomy – A review of 317 cases. The Journal of the American Association of Gynecologic Laparoscopists, 10(2), 166-168, 2003. Agarwala, N., Liu, C. Y. Long term results of Laparoscopic Burch Colposuspension. Submitted to The Journal of American Association of Gynecologic Laparoscopists. Agarwala, N., Liu, C. Y. Urinary Incontinence in Women and Current Treatments. Chapter for a book published in Argentinia. Agarwala, N., Nair, S.G., Ghosh, T.K. Experience with Neoadjuvant Methotrexate, Vincristine, Adriamycin, Cisplatin (MVAC) in Locally Advanced Cervical Carcinoma Proceedings of American Society of Clinical Oncology 2000; vol.19; 9: 1569. Agarwala, N and Gay, C.V. Specific Binding of Parathyroid Hormone to Living 0steoclasts. Journal of Bone and Mineral Research 1992; vol. 7; 9: 531-539. Snipes, W and Agarwala, N. The Molecular Basis of Human Disease and approaches to its treatment. Science and People – The Woodburn Press, 1993. ISBN 0-9612798-5-0. This book was intended for youngsters to motivate them to study life sciences, and for a large adult population that had little knowledge of human diseases. Continuing Medical Education American College of Obstetricians and Gynecologists, 53rd Annual Clinical Meeting, San Francisco, May, 2005. International Congress of Gynecologic Endoscopy AAGL 33rd Annual Meeting, San Francisco, November, 2004 American College of Obstetricians and Gynecologists, 52nd Annual Clinical Meeting, Philadelphia, May, 2004. International Congress of Gynecologic Endoscopy AAGL 32nd Annual Meeting, Las Vegas, November, 2003 PG Courses: Complications of Laparoscopic Surgery, Hysterectomy Alternatives. Plenary session speaker: Laparoscopic Uterosacral Vault or Uterine Suspension Osler Institute Review Course in Obstetrics and Gynecology, Philadelphia, May, 2003 International Congress of Gynecologic Endoscopy AAGL 31st Annual Meeting, Miami, November, 2002 PG Courses: Laparoscopic Surgery-Outer limits, Laparoscopic Pelvic Floor reconstruction. Plenary session speaker: Laparoscopic Appendectomy Experience. International Congress of Gynecologic Endoscopy AAGL 30th Annual Meeting, San Francisco, November, 2001 PG Courses: Laparoscopic Management of Endometriosis, Laparoscopic Urogynecology American College of Obstetricians and Gynecologists District III, 2000 Annual Meeting, Philadelphia, October, 2000 Poster Presentation: Experience with Neoadjuvant MVAC in Locally Advanced Cervical Cancer. Obstetrics and Gynecology Review Course, Chicago Area Schools of Medicine, Chicago, June, 2000. American Society of Clinical Oncology Poster Presentation: Experience with Neoadjuvant MVAC in Locally Advanced Cervical Cancer. Advances in Gynecologic Surgery and Oncology 36th Annual Clinical Meeting, New Orleans, May, 2000 Course Directors: Dr. Philip DiSaia and William T. Creaseman Seventeenth Annual Houston Everett Memorail Course in Urogynecology Course Director: Dr. Cundiff, Johns Hopkins, Baltimore, February, 2000 American College of Obstetricians and Gynecology ACOG 47th Annual Clinical Meeting, Philadelphia, May, 1999 Clinical Seminars: Preeclampsia and Hypertension: Prevention and Management, Gynecologic Oncology for the general OB/GYN, Management of abnormal pap smears. International Congress of Gynecologic Endoscopy AAGL 27th Annual Meeting, Atlanta, November, 1998 PG Courses: Pelvic Floor Reconstruction, Laparoscopic Hysterectomy Advances in Female Voiding Dysfunction and Pelvic Disorders Conducted by The Cleveland Clinic Foundation, October, 1998 Course Directors: Rodney A. Appell, M.D. and Mark D. Walters, M.D. Advanced Endoscopic Surgery with hands-on laparoscopy lab Conducted by AAGL and Ethicon Endo-Surgery Institute, August, 1998 Course Directors: Grace M Janik, M.D. and Charles H. Koh, M.D. Advanced Endoscopic Gynecologic Surgery with hands-on lapraroscopy lab Conducted by AAGL and Ethicon Endo-Surgery Institute, June, 1998 Course Directors: Mark W. Surrey, M.D., Thomas L. Lyons, M.D., and C. Y. Liu, M.D. All Michigan OB/GYN Review Course – May 18-22,1998 Advanced Gynecological Surgery Course Directors: Michael S. Baggish, M.D. and John L. Marlow, M.D., January, 1998 Advances in Gynecology: Modem Management of Uterine Fibroids and Endometriosis, Palm Springs,1995 Presentations Women’s Watch Program – Lecture on Urinary Incontinence in Women, May 2005. Cadaver Lab, Laparoscopic Principles Workshop, Urogynecology Procedures Resident Lecture Series, 2004-2005. It happens to the best of Us – Speaker at the Olson Center Brown Bag Lecture Series, University of Nebraska Medical Center, Omaha, April 2005. Management of Overactive Bladder- Trospium as a new medication– Speaker at Urology and Family Practice Groups, Sioux Falls, March, 2005. Urodynamic Principles, Resident Lecture Series, March, 2005. Urogynecological Surgery, Laparoscopic Hysterectomy and Menopause – Operating Room Personell Morning Lecture Series, University of Nebraska Medical Center, Three lectures in 2004 Management of Overactive Bladder – Speaker at Family Practice Grand Rounds, University of Nebraska Medical Center, Omaha, September 2004. Laparoscopic Hysterectomy – Wyeth Representative Teaching Program, March 2004. Advances in Hysteroscopic surgery – Grand Rounds, Department of Obstetrics and Gynecology, University of Nebraska Medical Center, March 2004. There is help for Incontinence – Nursing Students Educational Program, University of Nebraska, Omaha, April 2004-5. Management of Overactive Bladder – Speaker at four outreach programs, University of Nebraska Medical Center, Omaha, January- February 2004. There is help for Incontinence – Speaker at the Olson Center Brown Bag Lecture Series, University of Nebraska Medical Center, Omaha, January 2004. What’s New in Incontinence – Grand Rounds, Department of Obstetrics and Gynecology, University of Nebraska Medical Center, August 2003. Advanced Laparoscopy – Grand Rounds, Department of Obstetrics and Gynecology, University of Nebraska Medical Center, March 2003. Evaluation of Incontinence – 32nd, 33rd and 34th Annual Family Practice Review Course, Best practices for the 21st century, University of Nebraska Medical Center, April 2003-5. Surgical Anatomy, Laparoscopic Evaluation of the pelvis, Electrosurgical principles in surgery – Resident Lectures, Department of Obstetrics and Gynecology, University of Nebraska Medical Center, 2002-2003. Pelvic Organ Prolapse and Urinary Incontinence – 3rd year Student Lectures, Department of Obstetrics and Gynecology, University of Nebraska Medical Center, 2002-2005. Normal reproduction and Infertility – 2nd year Medical Student Lecture, College of Medicine, University of Nebraska Medical Center, 2002-2004. Normal menstrual cycle, Menorrhagia and Metrorrhagia – 2nd year Medical Student Lecture, College of Medicine, University of Nebraska Medical Center, 2002-2005. The menstrual cycle and abnormalities – Introduction to Medicine Lecture, Physician Assistant Program, University of Nebraska Medical Center, 2002-2004. There is help for Incontinence – Speaker at the Spring Women’s Conference, Renew, Refresh, Revive: A Day of Women’s Wellness, Omaha, March 2003. Common Medical Conditions of Aging – Speaker at the 6th Annual Omaha Women’s Health and Wellness Conference, October 2003. Surgical principles of Incontinence Surgery – Women’s Lecture Series at the Eastridge Hospital, Chattanooga, April 2002. Certification American Board of Obstetrics and Gynecology (ABOG) Oral Examination– completed in 12/04 Written examination for ABOG -completed in 6/2001. Completed United States Medical Licensing Examinations Step-I. II, and III. CREOG In-Training Examination-Standardized scores: 242 -PGY-1, 239 -PGY-2, 236 -PGY-3&4 Licensure Licensed to practice in the state of Pennsylvania, Nebraska and Tennessee Memberships The American Association of Gynecological Laparoscopists, The American College of Obstetricians and Gynecologists, American Medical Association, Alpha Omega Alpha, California Medical Association and Pennsylvania Medical Society, American Association for Advancement of Science.Read More

يونيو – حزيران 2003 سيد عزيزة خبازة ، التقى اللجنة على [نون-غفرنمنتل ورغنيزأيشن] من القسم من معلومة عامّة ([دبي]) في يونيو – حزيران أن يعتبر [نو بّليكأيشن] من [نون-غفرنمنتل ورغنيزأيشن] ([نغس]) لجمعية مع [دبي]. أنا سررت أن يعلم أنت أنّ وافق اللجنة نساء صحة وتربية مركز ([وهك]) لجمعية مع القسم ، فعّالة فورا. يمثّل هذا جمعية تعهد [أن ث برت وف] تنظيمك أن ينشر معلومة ورفعت [بوبليك ورنسّ] حول الأغراض وأنشطة من الالأمم المتّحدة وإصدارات من اهتمام شاملة. توقّعت [نغس] موحّدة أن ركّز على جزء من هم نشر ومعلومة أنشطة على العمل من الالأمم المتّحدة. أنت شجّعت أن يتعاون مع الالأمم المتّحدة معلومة [سنترس] أو خدمات في بلدك ومع ممثلات من أخرى أجزاء من الالأمم المتّحدة في المنطقة من خبرتك. أنت أيضا توقّعت أن يحافظ ال [دبي/نغو] قسم يعلم من الأنشطة أنت ب قام وأن يرسلنا نشر موافقة وأخرى [متريلس]. أرسلتنا [إين ث كس وف] تعديل إلى ك [أرغنيزأيشنل ستروكتثر] أو قانون داخليّ ، رجاء نسخة من ال يعّدّل وثائق. أيضا ، أنت سوفت أعلمت نا من كلّ تغيرات في ك اسم أو عنوان أو ممثلات إلى هذا قسم. في هذا إحترام ، أحبّ أنا أن يأخذ هذا فرصة أن يعلم أنت أنّ ك [نغّ] موحّدة ، أنت خوّلت أن يعيّن واحدة رئيسيّة وواحدة ممثلة بديلة ، الذي كنت سيمنح الأمم المتّحدة صورة أراضي ممرات أيّ يكون متجدّدة سنويّا. رجاء ملأت خارجا ورجعت المتضمّنة 2003 اعتماد شكل. رجاء لاحظت أنّ ممثلتك سوفت أتيت إلى ال [نغو] موردة مركز في شخص أن يستلم الأراضي ممر. سيعطي الممر ممثلتك منفذة إلى الأمم المتّحدة تسهيلات وإلى كلّ يفتح اجتماعات من الالأمم المتّحدة أجسام ، أيّ هم يستطيع حضرت كملاحظات. دعات ممثلات أيضا أن يحضر اليوم الخميس [نغو] شرح مهمّة ينظّم بالقسم ، يظهر الأمم المتّحدة مسؤولات ، حكومة مندوبات وأخرى خبيرات ، بما في ذلك [نغس]. Mr. Benton Baker III President Women’s Health and Education Center (WHEC) 300 Stafford Street, Suite 265 Springfield, MA 01104 سيعدّل تنظيمك أيضا كنت على دليلنا ال [نغس] يصحب مع [دبي] ، أيّ يكون نشرت في طبعة شكل وعن طريق [وب ست] نا يلاحظ أدناه. ممثلاتك مرحّبة أن يستشير الأمم المتّحدة يطبع ، سمعيّة ويركّز [متريلس] مرئيّة في ال [نغو] موردة. ال [نغو] يقدّم قسم أيضا سنويّة توجيه برنامج ل حديثا يعتمد [نغو] ممثلات. نحن سنعلم أنت من التاريخ من البرنامج تالية سيبدأ تنظيمك يستلم مراسلات شهريّة من موافقة الأمم المتّحدة [متريلس] ومعلومة على الأمم المتّحدة مؤتمرات ، حلقة دراسيّة ، شرح مهمّة وأخرى حادثات. سيرسل هذا [متريلس] كنت إلى مقرّ رئيسيّك ما لم أنت تأمرنا أن يرسلهم في مكان آخر. معلومة على هذا حادثات أيضا يتوفّ www.un.org/dpi/ngosection. على [وب ست] نا في: أنا أحبّت أن يعلم أنت أنّ لا يمثّل جمعية ال [نغس] مع [دبي] إندماجهم داخل الالأمم المتّحدة نظامة ، ولا هو يخوّل تنظيمات موحّدة أو ملاكتهم إلى أيّ نوع من امتيازات ، مناعة أو وضع خاصّة لاحظت رجاء أيضا أنّ فقط الالأمم المتّحدة يستطيع استعملت المنظّمة الأمم المتّحدة شعار. المنظّمة الأمم المتّحدة شعار يمكن لا يكون استعملت ما لم موافقة يتلقّى يكون منحت ب ال جائز مكتب من المنظّمة الأمم المتّحدة. أنت يمكن أحلت جمعيتك مع [دبي] [إين ث فولّووينغ وي]: الاسم من تنظيمك يتبع بعبارة مثل “يصحب مع القسم من معلومة عامّة من الالأمم المتّحدة”. أحلتبنفسي على [بوسنسّ كرد] ك ، رجاء كممثلة من تنظيمك يصحب مع القسم من معلومة عامّة من الالأمم المتّحدة. هو كان غيرصحيح أن يحيلبنفسي ك [أ’] مندوبة أو ممثلة إلى المنظّمة الأمم المتّحدة بما أنّ هذا عبارات يستطيع فقط كنت استعملت ب [ممبر ستتس]. نظرت ثانية ، هو متعتي أن يرحّب تنظيمك بين [نغس] يصحب مع [دبي] وأن يؤكّد أنت أنّ بنفسي والملاكة من ال [دبي/نغو] قسم ، إلى الأمام إلى مشاركة منتجة في المطاردة من أهدافنا عاديّة. خاصّتي بإخلاص ، Paul Hoeffel Chief NGO Section Department of Public Information cc: Mr. Sommereyns Mrs. J. Levy, Chairperson, NGO/DPI Executive Committee UNIC WashingtonRead More

Chief of Obstetrics and Gynecology Brigham and Women’s Hospital Department of Obstetrics and Gynecology, ASB1-3, Boston, Massachusetts (USA) Robert L. Barbieri, M.D. graduated from Yale College (1973) and Harvard Medical School (1977). He is certified in Internal Medicine (1982), Endocrinology and Metabolism (1983), Obstetrics and Gynecology (1987) and Reproductive Endocrinology and Infertility (1988). Currently he is Chairman of Obstetrics and Gynecology at the Brigham and Women’s Hospital and the Kate Macy Ladd Professor of Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School. Dr Barbieri is the program director for the integrated Brigham and Women’s Hospital-Massachusetts General Hospital obstetrics and gynecology residency training program. Dr. Barbieri is the past President of the Association of Professors of Gynecology and Obstetrics (APGO), and the past President of the APGO Medical Education Foundation. He has served on the Board of Directors of the American Society of Reproductive Medicine and as the Chairperson of the National Institutes of Health, Reproductive Biology Study Section. Dr. Barbieri is a contributing author to over 300 medical publications. He is an editor of 4 textbooks in reproductive endocrinology and gynecology: UpToDate in Obstetrics, Gynecology and Women’s Health, Kistner’s Gynecology and Women’s Health, Yen and Jaffe’s Reproductive Endocrinology and Scientific American Medicine: Gynecology in Primary Care. He is a co-author of 6 Steps to Increased Fertility, a Harvard Medical School book, published by Simon and Schuster. His current research interests include issues related to infertility, including the treatment of PCOS and the identification of predictors of successful IVF treatment.Read More

الغرض من صحة المرأة ومركز التعليم (WHEC) لدعم وتحسين فرص التعليم والصحة العامة للنساء وخاصة النساء من البلدان النامية. صحة المرأة والوضع في غاية التعقيد والصعوبة لقضية البلدان النامية والصناعية على حد سواء. المرأة تواجه عقبات ضخمة — التحيز ، والنبذ ، والعنف المنزلي ، والفقر ، والجوع ، ويكاد لا يحصلون على الرعاية الطبية والأدوية المنقذة للحياة. المرأة والصحة والتعليم ومركز مخصص لصحة المرأة ورفاهها في جميع أنحاء العالم. موقعها على شبكة الإنترنت ، WomensHealthSection.com هي للأغراض التعليمية ، وبين الولايات المتحدة والبلدان النامية : المنفعة المتبادلة والاحترام المتبادل. ونحن نؤيد ومساعدة المشاريع والبرامج في مجال صحة المرأة ، والتعليم والبحوث. ونعتقد : وعلى هذا المسار لم يذهب إلى جهد النفايات ، وليس هناك فشل. في كل عام أكثر من 500 ، 000 امرأة تموت أثناء الحمل أو الولادة ، وأقل من 10 ملايين طفل يموتون قبل عيد ميلادهم الخامس بين ما يقرب من 40 ٪ من هؤلاء في الشهر الأول من الحياة. ولكن الدلائل تشير الى ان ما لا يقل عن 6 ملايين دولار من هذه يمكن إنقاذ حياة كل عام ثبت ، التدخلات الفعالة من حيث التكاليف. رؤيتنا : عالم فيه كل من النساء والأطفال في الحصول على ما يحتاجونه من رعاية صحية في العيش ، وحياة منتجة. هدفنا : الاستثمار في تقديم ودفع الأم والوليد والطفل والصحة ، وبالتالي وضعت 50 ٪ من عبء ارتفاع 60 بلدا “على الطريق” لتحقيق الأهداف الإنمائية للألفية 4 و 5 في 5 سنوات. ماذا نفعل؟ المرأة والصحة والتعليم ومركز WHEC) المدافعين عن المساواة بين الجنسين في مجالي الصحة والتعليم للنساء والفتيات في جميع أنحاء العالم. WHEC يجلب الانتباه إلى الطرق التي البيولوجية والاجتماعية والثقافية والعوامل التي تؤثر على صحة النساء والرجال والصبية والفتيات. WHEC تهدف إلى زيادة المعرفة وتعزيز استجابة القطاع الصحي من خلال جمع الأدلة ، وتعزيز القدرات المحلية والمشاركة في الدعوة إلى المساواة بين الجنسين وعلى الطريقة التي تؤثر على الصحة وعدم المساواة بين الجنسين. WHEC يركز على الطرق بين الجنسين ، والبناء الاجتماعي ، ويؤثر على صحة الرجال والنساء على السواء. ولكن علينا أيضا أن ندرك أن عدم المساواة بين الجنسين قد أعلى تبعات ضارة على صحة النساء بسبب التمييز الذي يواجهونه في كل ثقافة. عدم المساواة بين الجنسين يزيد من حدة الآثار الضارة الناجمة عن الفقر ونقص التعليم على صحة المرأة ، مما يعوق قدرة الملايين من النساء في جميع أنحاء العالم من الحصول على الرعاية الصحية وتحقيق أفضل مستوى ممكن من الصحة. WomensHealthSection.com تثقيف مهنيي الرعاية الصحية عن الظروف التي تقتصر على النساء ، وأكثر انتشارا بين النساء ، أو تشخيص أو معاملة مختلفة من النساء في مقابل الرجال. ويعرض هذا المنشور غير متحيزة وشاملة وموجزة ، وسريريا المواد ذات الصلة ، وعملية استعراض الأبواب. هذه المواد التي خضعت لاستعراض نظير للحفاظ على أعلى مستوى من الجودة والتحقق من ملاءمة السريرية والطبية والدقة ، والوضوح في العرض. أكثر الثاقبة وشاحذة للفكر المواد متاحة الآن في موقع واحد. جميع ممارسات WHEC نشرات تستعرض 18 و 24 شهرا بعد نشر والمنقحة ، من جديد ، أو سحبها. الجنسانية والصحة لماذا؟ الاختلافات بين الجنسين على حد سواء وعدم المساواة بين الجنسين يمكن أن تؤدي إلى عدم المساواة بين الرجل والمرأة في الوضع الصحي والحصول على الرعاية الصحية. على سبيل المثال : لا يمكن للمرأة الحصول على الخدمات الصحية اللازمة لمعايير مجتمعها في منعها من السفر وحده إلى عيادة. وفاة فتى في حادث بسبب تحاول أن ترقى إلى مستوى أقرانهم توقعات بأن الشباب يجب ان تكون “جريئة” بأخذ مخاطر. المرأة المتزوجة عقود بسبب فيروس نقص المناعة البشرية والمعايير المجتمعية تشجيع ممارسة الجنس مع زوجها في الوقت نفسه على منعها من الإصرار على استخدام الواقي الذكري. بلد يبلغ معدل وفيات سرطان الرئة بين الرجال بكثير من المعدل المناظر للنساء بسبب التدخين يعتبر جذابا علامة الرجولة ، في حين أنه من غير أنثوي مستهجنه كما في المرأة. في كل حالة من هذه الحالات ، ونوع الجنس والمعايير والقيم ، وما نجم عنها من سلوكيات ، ويؤثر سلبا على الصحة. وفي الواقع ، فإن صورة الجنسين في وقت معين ومكان يمكن أن يكون واحدا من العقبات الرئيسية — في بعض الأحيان أهم عقبة — الوقوف بين الرجل والمرأة ، وتحقيق الرفاهية. WHEC ، وقد أصدر سلسلة من الصفحات على معلومات ذات صلة بين الجنسين إلى عدة مشاكل صحية محددة. أكثر من قراءتها ، هو وسيلة جيدة لبدء الحصول على شعور سبل التفاعل بين الجنسين والصحة. WomensHealthSection.com هي عالمية ، قابلة للاستخدام على الشبكة منبرا لأشكال متعددة من التعاون. هذه المنصة تمكن الأفراد والجماعات والشركات والجامعات في أي مكان في العالم للتعاون — لأغراض الابتكار والتعليم والبحث وأسباب التقدم في السلام والصحة والتنمية. ندعوكم للاستفادة من هذه المنصة ، وأخيرا ، فإن الحكم للحصول على أفضل النتائج من هذه المنصة.Read More